Synonyms: (E)-4-((4-(4-(1H-1,2,3-triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole; 1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole; CID 6444692; TAK 165; TAK-165
Molecular Formula: C25H23F3N4O2
Molecular Weight: 468.47
Linear Structural Formula: C25H23F3N4O2
MDL Number: MFCD09954135
Purity: >=98% (HPLC)
Storage: 2-8C
Biochem Physiol Actions: Mubritinib (TAK-165) is a potent and selective inhibitor of the human epidermal growth factor receptor 2 ErbB (HER2) tyrosine kinase. Mubritinib potently inhibits proliferation of cancer cell lines over- expressing ErbB2.